Plasma, platelets and cryoprecipitates therapies

Authors

  • Vanessa Agostini UO Medicina Trasfusionale IRCCS Ospedale Policlinico San Martino, Genova. Centro Regionale Sangue-Liguria - Italy

DOI:

https://doi.org/10.33393/ao.2022.2432

Keywords:

Blood platelets, Cryoprecipitates, Plasma, Platelet transfusion, Transfusion therapy

Abstract

The present review gives an overview of the components, applications and risks of transfusion therapy. Fresh frozen plasma (FFP) transfusion is a widely used procedure both in a prophylactic and therapeutic context. In both scenarios the method of administration and the dosage are, improperly, the same; it is reported that in the clinical context FFP is inappropriately used in over 50% of cases.  According to different guidelines its only recommended use is in a condition of critical hemorrhage, as there is no evidence of positive outcomes in its prophylactic administration. Platelet concentrates (PCs) are broadly used to support patients with thrombocytopenia, whether it is pre or postoperative, or in intensive care medicine. The only consensus on its use is the prophylactic administration when the patient’s platelet count is lower than 10,000. Another use of PCs can be in reducing side effects and enhancing the effects of specific drugs, although this application is still complex. Cryoprecipitate usage in clinics is decreasing both due to its variable content of factors I, VIII, XIII and von Willebrand, and the amount of time necessary to obtain it. Of great importance in the transfusion therapy framework are the respiratory complications that can occur, such as Transfusion-Associated Cardiac Overload (TACO), Transfusion-Related Acute Lung Injury (TRALI), Transfusion-Associated Dyspnea (TAD) and transfusion-induced sepsis. The suggested procedure when any of these (and other) complications occur is to seek consultation from the transfusion medicine unit.

References

European Committee (Partial Agreement) on Blood Transfusion. (CD-P-TS). Guide to the preparation, use and quality assurance of blood components. In: EDQM 20th Edition.; 2020. Online https://www.edqm.eu/en/blood-guide

Gazzetta Ufficiale della Repubblica Italiana. Ministero della Salute. Decreto 2 novembre 2015. Disposizioni relative ai requisiti di qualità e sicurezza del sangue e degli emocomponenti. (15A09709). GU Serie Generale n.300 del 28-12-2015 - Suppl. Ordinario n.69. Accessed May 4, 2022. https://www.gazzettaufficiale.it/eli/id/2015/12/28/15A09709/sg

Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D; Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care. 2011;15(2):R108-R108. https://doi.org/10.1186/cc10129 PMID:21466676

Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006;46(8):1279-1285. https://doi.org/10.1111/j.1537-2995.2006.00891.x PMID:16934060

Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol. 2006;126(1):133-139. https://doi.org/10.1309/NQXHUG7HND78LFFK PMID:16753596

Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DBL, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126(1):139-152. https://doi.org/10.1111/j.1365-2141.2004.04973.x PMID:15198745

Roback JD, Caldwell S, Carson J, et al; American Association for the Study of Liver; American Academy of Pediatrics; United States Army; American Society of Anesthesiology; American Society of Hematology. Evidence-based practice guidelines for plasma transfusion. Transfusion. 2010;50(6):1227-1239. https://doi.org/10.1111/j.1537-2995.2010.02632.x PMID:20345562

National Blood Authority of Australia. Patient Blood Management Guidelines. 2012. Accessed May 4, 2022. https://www.blood.gov.au/pbm-guidelines

Executive Committee of the German Medical Association on the Recommendation of the Scientific Advisory Board. Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised. Transfus Med Hemother. 2016;43(3):223-232. https://doi.org/10.1159/000446043 PMID:27403094

Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol. 2017 Jun;34(6):332-395. https://doi.org/10.1097/eja.0000000000000630 PMID: 28459785

Green L, Bolton-Maggs P, Beattie C, et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding. Br J Haematol. 2018;181(1):54-67. https://doi.org/10.1111/bjh.15167 PMID:29527654

Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia. 2016;71(7):829-842. https://doi.org/10.1111/anae.13489PMID:27062274

Raphael J, Mazer CD, Subramani S, et al. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. Anesth Analg. 2019;129(5):1209-1221. https://doi.org/10.1213/ANE.0000000000004355 PMID:31613811

Vlaar AP, Oczkowski S, de Bruin S, et al. Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. 2020;46(4):673-696. https://doi.org/10.1007/s00134-019-05884-8PMID:31912207

Makris M, Van Veen JJ, Tait CR, Mumford AD, Laffan M; British Committee for Standards in Haematology. Guideline on the management of bleeding in patients on antithrombotic agents. Br J Haematol. 2013;160(1):35-46. https://doi.org/10.1111/bjh.12107 PMID:23116425

Wada H, Thachil J, di Nisio M, et al. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11(4):761-767. https://doi.org/10.1111/jth.12155

Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;73(1):366-413. https://doi.org/10.1002/hep.31646 PMID:33219529

Patel IJ, Rahim S, Davidson JC, et al. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019;30(8):1168-1184.e1. https://doi.org/10.1016/j.jvir.2019.04.017 PMID:31229333

O’Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA Clinical Practice Update: coagulation in Cirrhosis. Gastroenterology. 2019;157(1):34-43.e1. https://doi.org/10.1053/j.gastro.2019.03.070 PMID:30986390

Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. Am J Gastroenterol. 2020 Jan;115(1):18-40. https://doi.org/10.14309/ajg.0000000000000486 PMID: 31895720

Kaufman RM, Djulbegovic B, Gernsheimer T, et al; AABB. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205-213. https://doi.org/10.7326/M14-1589 PMID:25383671

Godier A, Albaladejo P, On Perioperative Haemostasis Gihp Group TFWG; On Perioperative Haemostasis Gihp Group TFWG. Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls. J Clin Med. 2020;9(7):2318. https://doi.org/10.3390/jcm9072318 PMID:32708228

Curry N, Rourke C, Davenport R, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115(1):76-83. https://doi.org/10.1093/bja/aev134 PMID:25991760

Schäfer N, Driessen A, Fröhlich M, Stürmer EK, Maegele M; TACTIC partners. Diversity in clinical management and protocols for the treatment of major bleeding trauma patients across European level I Trauma Centres. Scand J Trauma Resusc Emerg Med. 2015;23(1):74. https://doi.org/10.1186/s13049-015-0147-6 PMID:26428070

Grey S, Bolton-Maggs P. Pulmonary complications of transfusion: Changes, challenges, and future directions. Transfus Med. 2020;30(6):442-449. https://doi.org/10.1111/tme.12709PMID:32924216

Narayan S, ed. Poles D et al. The Serious Hazards of Transfusion (SHOT) Steering Group. The 2018 Annual SHOT Report (2019). Online https://www.notifylibrary.org/sites/default/files/SHOT%20Annual%20Report%202018.pdf (Accessed May 2022)

Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774-1789. https://doi.org/10.1111/j.0041-1132.2004.04347.x PMID:15584994

Andrzejewski C. BMPGS et al. International Society of Blood Transfusion, Working Party on Haemovigilance in collaboration with The International Haemovigilance Network and AABB (formerly the American Association of Blood Banks). Transfusion-associated circulatory overload (TACO). Definition; 2018. Online https://www.aabb.org/docs/default-source/default-document-library/resources/taco-2018-definition.pdf?sfvrsn=e1bcfce4_0 (Accessed January 2021).

Published

2022-07-31

How to Cite

1.
Agostini V. Plasma, platelets and cryoprecipitates therapies. abtpn [Internet]. 2022 Jul. 31 [cited 2022 Oct. 1];9(1):52-7. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2432

Issue

Section

Focus on the management of critical bleeding